Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MODIFICATION TO HYPERQ SYSTEM

K-Number: K072389 · 2007-09-18

ApplicantBiological Signal Processing, Ltd.
Decision Date2007-09-18
Product CodeMWI
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

MODIFICATION TO HYPERQ SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Biological Signal Processing, Ltd.. It received FDA 510(k) clearance on 2007-09-18 under 510(k) number K072389. The device is classified under product code MWI. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MODIFICATION TO HYPERQ SYSTEM?

MODIFICATION TO HYPERQ SYSTEM is a medical device that received FDA 510(k) clearance on 2007-09-18. The listed applicant is Biological Signal Processing, Ltd.. The 510(k) number is K072389.

When did MODIFICATION TO HYPERQ SYSTEM receive FDA 510(k) clearance?

MODIFICATION TO HYPERQ SYSTEM received FDA 510(k) clearance on 2007-09-18, under 510(k) number K072389.

Who is the listed applicant for MODIFICATION TO HYPERQ SYSTEM?

The FDA 510(k) record lists Biological Signal Processing, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MODIFICATION TO HYPERQ SYSTEM?

The FDA product code for MODIFICATION TO HYPERQ SYSTEM is MWI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Biological Signal Processing, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K102579HYPERQ AD-100 SYSTEMK082564HYPERQ SYSTEMK070624HYPERQ SYSTEMK042981HYPERQ SYSTEM

Related Devices (Code: MWI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260438Vital Signs Monitor (CLEO2)Infinium Medical, Inc.K253417Masimo Root Monitoring SystemMasimo CorporationK253196Midmark 800 Digital Vital Signs Device (1-300-0100, 1-300-0200, 1-300-0300, 1-300-0400)Midmark CorporationK253436c-med0 alphaCosinuss GmbHK250135WAVE Clinical Platform (2.0.000)Baxter Healthcare Corp/ Excel MedicalK241766QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid)Fysicon BV

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑